ISPE and Gilead Sciences have partnered up for the establishment of an internship program.
According to a Dec. 8, 2020 press release, the International Society for Pharmaceutical Engineering (ISPE) and Gilead Sciences have partnered up for the establishment of an internship program.
The ISPE Foundation Diversity Internship Program is a 12-week course, which will take place in the summer months, offering graduate students and undergraduate students the opportunity of working on high-priority, impactful engineering and facilities projects and workstreams in Gilead’s Corporate Operations organization. Currently, two internship opportunities are available at Gilead: Mechanical engineering with a focus on energy/sustainability; and electrical engineering with a focus on process control/automation.
“It is a privilege to partner with Gilead on the launch of a program that will be truly life changing to the careers of a diverse pool of talented students and future leaders in the pharmaceutical field,” said Antonio Moreira, PhD, ISPE Foundation Board chair, vice provost, Academic Affairs, University of Maryland Baltimore County, in the press release. “The ISPE Foundation Diversity Internship Program interns will be immersed in creative and innovative projects, they will be connected with role models and senior leaders at Gilead, and they will be encouraged to let their imagination go to places they had not thought possible. I can't think of a more inspiring and energizing way to start my role as the ISPE Foundation Chair.”
“Gilead is committed to investing in the next generation of engineers and are pleased to partner with the ISPE Foundation on this program,” added Joydeep Ganguly, senior vice-president of Corporate Operations at Gilead, in the press release. “We believe that diverse teams are inherently strong teams and look forward to the ways these interns will contribute to our highest priority projects.”
Source: ISPE
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.